berberine has been researched along with Lymphoma, Large B-Cell, Diffuse in 3 studies
Lymphoma, Large B-Cell, Diffuse: Malignant lymphoma composed of large B lymphoid cells whose nuclear size can exceed normal macrophage nuclei, or more than twice the size of a normal lymphocyte. The pattern is predominantly diffuse. Most of these lymphomas represent the malignant counterpart of B-lymphocytes at midstage in the process of differentiation.
Excerpt | Relevance | Reference |
---|---|---|
" Here, in diffuse large B-cell lymphoma (DLBCL), serum metabolomic analysis revealed that oncogenic MYC could induce aberrant choline metabolism by transcriptionally activating the key enzyme phosphate cytidylyltransferase 1 choline-α (PCYT1A)." | 7.85 | MYC is a positive regulator of choline metabolism and impedes mitophagy-dependent necroptosis in diffuse large B-cell lymphoma. ( Chen, SJ; Fei, XC; Gale, RP; Janin, A; Jiang, XF; Li, B; Wang, CF; Wang, L; Xiong, J; Zhao, WL; Zhao, Y; Zheng, Z, 2017) |
" Here, in diffuse large B-cell lymphoma (DLBCL), serum metabolomic analysis revealed that oncogenic MYC could induce aberrant choline metabolism by transcriptionally activating the key enzyme phosphate cytidylyltransferase 1 choline-α (PCYT1A)." | 3.85 | MYC is a positive regulator of choline metabolism and impedes mitophagy-dependent necroptosis in diffuse large B-cell lymphoma. ( Chen, SJ; Fei, XC; Gale, RP; Janin, A; Jiang, XF; Li, B; Wang, CF; Wang, L; Xiong, J; Zhao, WL; Zhao, Y; Zheng, Z, 2017) |
" In this study, we employed the CCK8 assay to reveal that DCZ0358 inhibited proliferation in a dependent manner of time and dosage of DLBCL cells." | 1.91 | Berberine derivative DCZ0358 induce oxidative damage by ROS-mediated JNK signaling in DLBCL cells. ( Feng, Q; Gao, X; Hu, H; Hu, K; Jia, X; Li, B; Lu, Y; Peng, Y; Shi, J; Song, D; Wang, G; Wu, X; Xu, Z; Yi, H; Zhang, H; Zhang, Q; Zhu, H; Zhu, W, 2023) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Feng, Q | 1 |
Hu, K | 1 |
Hu, H | 1 |
Lu, Y | 1 |
Zhang, H | 1 |
Wang, G | 1 |
Zhang, Q | 1 |
Xu, Z | 1 |
Gao, X | 1 |
Jia, X | 1 |
Zhu, H | 1 |
Song, D | 1 |
Yi, H | 1 |
Peng, Y | 1 |
Wu, X | 1 |
Li, B | 2 |
Zhu, W | 1 |
Shi, J | 1 |
Ren, S | 1 |
Cai, Y | 1 |
Hu, S | 1 |
Liu, J | 1 |
Zhao, Y | 2 |
Ding, M | 1 |
Chen, X | 1 |
Zhan, L | 1 |
Zhou, X | 1 |
Wang, X | 1 |
Xiong, J | 1 |
Wang, L | 1 |
Fei, XC | 1 |
Jiang, XF | 1 |
Zheng, Z | 1 |
Wang, CF | 1 |
Chen, SJ | 1 |
Janin, A | 1 |
Gale, RP | 1 |
Zhao, WL | 1 |
3 other studies available for berberine and Lymphoma, Large B-Cell, Diffuse
Article | Year |
---|---|
Berberine derivative DCZ0358 induce oxidative damage by ROS-mediated JNK signaling in DLBCL cells.
Topics: Apoptosis; Berberine; Cell Line, Tumor; Humans; JNK Mitogen-Activated Protein Kinases; Lymphoma, Lar | 2023 |
Berberine exerts anti-tumor activity in diffuse large B-cell lymphoma by modulating c-myc/CD47 axis.
Topics: Adult; Aged; Animals; Antineoplastic Agents; Berberine; CD47 Antigen; Genes, myb; Humans; Lymphoma, | 2021 |
MYC is a positive regulator of choline metabolism and impedes mitophagy-dependent necroptosis in diffuse large B-cell lymphoma.
Topics: Berberine; Cell Line, Tumor; Choline; Choline-Phosphate Cytidylyltransferase; Humans; Lymphoma, Larg | 2017 |